Beudot C, De Méo M P, Dauzonne D, Elias R, Laget M, Guiraud H, Balansard G, Duménil G
Laboratoire de Biogénotoxicologie et Mutagénèse Environnementale (EA 1784), Université de la Méditerranée, Faculté de Pharmacie, 27 Bd Jean Moulin, 13385, Marseille Cedex 05, France.
Mutat Res. 1998 Sep 11;417(2-3):141-53. doi: 10.1016/s1383-5718(98)00103-x.
The mutagenic and antimutagenic activities of forty-two synthetic flavones were assessed by the Ames test. The tested flavones included twenty-three 3-nitroflavones, eighteen 3-aminoflavones and the 3-chloroflavone. The mutagenicity was evaluated with Salmonella typhimurium TA100 and YG1042 (an overproducing nitroreductase and O-acetyltransferase TA100 strain) with and without metabolic activation (S9 mix). The antimutagenicity of the non mutagenic derivatives was evaluated against 11 known reference mutagens. A total of 39 synthetic flavones were mutagenic. The mutagenic activities ranged from 0.1 rev/nmole (4'-chloro-6-methoxy-3-nitroflavone) to 6240 rev/nmole (4'-methoxy-3, 3'-diaminoflavone). Two differences were found between the 3-amino and the 3-nitroflavones: (i) the mutagenicity of the 3-aminoflavones required the presence of the metabolic activation; (ii) the 3-amino derivatives were more mutagenic than their 3-nitro counterparts. Increased mutagenicity, as assessed with strain YG1042, was limited to 17/39 derivatives. The mutagenic activity was induced by the presence of the double bond at the 2,3-position for conjugation of the lone-pair electron with the carbonyl group on the 'C' ring. This mutagenicity was modulated by substituents at the 2'-position. Additional mutagenicity was brought by the aminoaromatic and nitroaromatic group reduction by bacterial nitroreductases and by the S9 mix; it was modulated by different substituents on the aromatic rings of the flavones. Three flavones: 3-chloroflavone (1C), 4'-hydroxy-3-nitroflavone (23N) and 2',3-diaminoflavone (2A) showed antimutagenic properties. Compound 1C was efficient against benzo(a)pyrene (BaP), 2-aminofluorene (2AF), 2-aminoanthracene (2AA), 4-nitroquinoline-1-oxide (4NQO) and 1-methyl-3'-nitro-1-nitrosoguanidine (MNNG). Compound 23N inhibited the mutagenicity of BaP and MNNG. The antimutagenic activity of 2A was limited to MNNG.
通过艾姆斯试验评估了42种合成黄酮的致突变和抗突变活性。所测试的黄酮包括23种3 - 硝基黄酮、18种3 - 氨基黄酮和3 - 氯黄酮。用鼠伤寒沙门氏菌TA100和YG1042(一种过量表达硝基还原酶和O - 乙酰转移酶的TA100菌株)在有和没有代谢活化(S9混合物)的情况下评估致突变性。对11种已知的参考诱变剂评估非诱变衍生物的抗突变性。共有39种合成黄酮具有致突变性。致突变活性范围从0.1回复突变/纳摩尔(4'-氯-6 - 甲氧基-3 - 硝基黄酮)到6240回复突变/纳摩尔(4'-甲氧基-3,3'-二氨基黄酮)。在3 - 氨基黄酮和3 - 硝基黄酮之间发现了两个差异:(i)3 - 氨基黄酮的致突变性需要代谢活化的存在;(ii)3 - 氨基衍生物比其3 - 硝基对应物更具致突变性。用YG1042菌株评估时,致突变性增加仅限于17/39种衍生物。致突变活性是由2,3位的双键存在诱导的,用于孤对电子与'C'环上的羰基共轭。这种致突变性受到2'-位取代基的调节。细菌硝基还原酶和S9混合物对氨基芳香族和硝基芳香族基团的还原带来了额外的致突变性;它受到黄酮芳香环上不同取代基的调节。三种黄酮:3 - 氯黄酮(1C)、4'-羟基-3 - 硝基黄酮(23N)和2',3 - 二氨基黄酮(2A)表现出抗突变特性。化合物1C对苯并(a)芘(BaP)、2 - 氨基芴(2AF)、2 - 氨基蒽(2AA)、4 - 硝基喹啉-1 - 氧化物(4NQO)和1 - 甲基-3'-硝基-1 - 亚硝基胍(MNNG)有效。化合物23N抑制BaP和MNNG的致突变性。2A的抗突变活性仅限于MNNG。